Profusa (NVACW) EPS (Weighted Average and Diluted) (2022 - 2026)

Profusa has reported EPS (Weighted Average and Diluted) for 5 years, with the latest figure at -$2.05 in Q1 2026.

• For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) rose 98.05% year-over-year to -$2.05; the trailing twelve-month figure through Mar 2026 stood at $24.0 (up 105.22% YoY), and the FY2025 full-year result was -$107.01, up 70.04% from the prior year.
• EPS (Weighted Average and Diluted) for Q1 2026 stood at -$2.05, down from $89.25 in the prior quarter.
• The five-year high for EPS (Weighted Average and Diluted) was $89.25 in Q4 2025, with the low at -$353.54 in Q4 2024.
• Historically, EPS (Weighted Average and Diluted) has averaged -$25.63 across 5 years, with a median of -$0.07 in 2024.
• Annual changes were most pronounced in 2024 — EPS (Weighted Average and Diluted) tumbled 883950.0% — and 2025, when it surged 125.24%.
• Profusa's EPS (Weighted Average and Diluted) stood at -$0.71 in 2022, then surged by 105.6% to $0.04 in 2023, then sank by 883950.0% to -$353.54 in 2024, then surged by 125.24% to $89.25 in 2025, then tumbled by 102.3% to -$2.05 in 2026.
• The last three EPS (Weighted Average and Diluted) figures came in at -$2.05 (Q1 2026), $89.25 (Q4 2025), and -$61.67 (Q3 2025), per Business Quant data.